Benzinga's Top Initiations
January 28, 2016 at 09:53 AM EST
Analysts at Janney Capital initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating. Nektar Therapeutics shares ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.